contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-0502-embla-medical-og-spar-nord

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.  

Embla Medical

Spar Nord Bank conducts banking operations. The company offers a wide range of financial services to both private and corporate customers, which includes mortgages, private savings, pensions, and insurance, as well as asset management. A large part of the service is handled digitally via the bank's mobile bank. Spar Nord Bank was originally founded in 1824 and is headquartered in Aalborg, Denmark.

Spar Nord Bank

Dagens aktienyheder med Embla Medical og Spar Nord

Dagens aktienyheder 05/02: <a class="ql-mention" spellcheck="false" href="https://www.linkedin.com/company/54143576/admin/page-posts/published/#" data-entity-urn="urn:li:fsd_company:102137357" data-guid="0" data-object-urn="urn:li:organization:102137357" data-original-text="Embla Medical" data-test-ql-mention="true">Embla Medical</a> og <a class="ql-mention" spellcheck="false" href="https://www.linkedin.com/company/54143576/admin/page-posts/published/#" data-entity-urn="urn:li:fsd_company:11600" data-guid="1" data-object-urn="urn:li:organization:11600" data-original-text="Spar Nord" data-test-ql-mention="true">Spar Nord</a>
Embla har her til morgen aflagt Q4 2024 regnskab. Kvartalet kommer ud til den svage side, med 5% organisk v&#xe6;kst og dermed et lavere v&#xe6;ksttempo end de forrige kvartaler. Oms&#xe6;tning og EBIT resultater lander henholdsvis 2% og 6% under konsensus, men en del af dette ser ud til at v&#xe6;re valutaeffekter, da den organiske v&#xe6;kst kommer rimeligt ind som forventet. Fokus er dog p&#xe5; 2025 guidance, hvor selskabet forventer 5-8% organisk v&#xe6;kst (kons. 6,2%) og en EBITDA-margin p&#xe5; 20-21% (kons. 20,7%). Der var ventet en lidt konservativ guidance p&#xe5; grund af usikkerhed om mulige tarifer. Embla har langsigtede m&#xe5;l om at vokse 5-7% organisk, s&#xe5; positivt at se 8% med i toppen, g&#xe5;ende ind i det f&#xf8;rste &#xe5;r hvor de vil nyde godt af de forberede tilskudsmuligheder i USA, men at der tages 5% med i bunden vil der nok ogs&#xe5; blive spurgt ind til. VI afholder i dag et event med CEO, hvor du kan stille sp&#xf8;rgsm&#xe5;l live. https://www.inderes.dk/videos/embla-medical-presentation-of-q4-2024.
Spar Nord har her til morgen offentliggjort sit &#xe5;rsregnskab for 2024, der meget vel kan ende med at blive bankens sidste som selvst&#xe6;ndigt pengeinstitut set i lyset af det igangv&#xe6;rende overtagelsestilbud fra Nykredit. Selve regnskabet viser endnu et rekord&#xe5;r kun overg&#xe5;et af resultatet i 2023. L&#xe6;s hele vores kommentar her og tilmeld dig vores event senere i dag: https://www.inderes.dk/analyst-comments/spar-nord-arsregnskabet-for-2024-er-det-andet-bedste-i-bankens-historie
Spar Nord, er foruden at v&#xe6;re aktuelle med &#xe5;rsregnskab for 2024 (jf. ovenfor), pt. ogs&#xe5; i fokus med det overtagelsestilbud som Nykredit fremsatte d. 8. januar 2025 p&#xe5; kurs DKK 210 pr. aktie. I forbindelse med at Finanstilsynet har godkendt, at Nykredit kan &#xf8;ge sin kvalificerede ejerandel i Spar Nord til 100%, meddeler Nykredit at man har oplysninger om at acceptgr&#xe6;nsen for tilbuddet p&#xe5; 67% nu er n&#xe5;et. Heraf har Nykredit pt. en direkte ejerandel p&#xe5; 31,1% af aktierne i Spar Nord.
Disclaimer: HC Andersen Capital modtager betaling fra de n&#xe6;vnte selskaber for en digital IR/Corporate Visibility abonnementsaftale.
/Jesper Thomsen kl. 08:57 d. 05/02-2025